257 related articles for article (PubMed ID: 20206067)
21. The statin studies: from targeting hypercholesterolaemia to targeting the high-risk patient.
Ong HT
QJM; 2005 Aug; 98(8):599-614. PubMed ID: 16006501
[TBL] [Abstract][Full Text] [Related]
22. Effects of colesevelam hydrochloride on low-density lipoprotein cholesterol and high-sensitivity C-reactive protein when added to statins in patients with hypercholesterolemia.
Bays HE; Davidson M; Jones MR; Abby SL
Am J Cardiol; 2006 Apr; 97(8):1198-205. PubMed ID: 16616026
[TBL] [Abstract][Full Text] [Related]
23. [Statins in primary prevention of coronary heart disease].
Paulweber B
Wien Med Wochenschr; 1999; 149(5-6):129-38. PubMed ID: 10408004
[TBL] [Abstract][Full Text] [Related]
24. Pleiotropic effects of statins: benefit beyond cholesterol reduction? A meta-regression analysis.
Robinson JG; Smith B; Maheshwari N; Schrott H
J Am Coll Cardiol; 2005 Nov; 46(10):1855-62. PubMed ID: 16286171
[TBL] [Abstract][Full Text] [Related]
25. Titration patterns with rosuvastatin as compared with other statins in clinical practice: a retrospective observational cohort study using an electronic medical record database.
Fox KM; Gandhi SK; Ohsfeldt RL; Blasetto JW; Davidson MH
Clin Ther; 2007 Nov; 29(11):2385-94. PubMed ID: 18158079
[TBL] [Abstract][Full Text] [Related]
26. Baseline characteristics of participants in the JUPITER trial, a randomized placebo-controlled primary prevention trial of statin therapy among individuals with low low-density lipoprotein cholesterol and elevated high-sensitivity C-reactive protein.
Ridker PM; Fonseca FA; Genest J; Gotto AM; Kastelein JJ; Khurmi NS; Koenig W; Libby P; Lorenzatti AJ; Nordestgaard BG; Shepherd J; Willerson JT; Glynn RJ;
Am J Cardiol; 2007 Dec; 100(11):1659-64. PubMed ID: 18036365
[TBL] [Abstract][Full Text] [Related]
27. Comparison of incidences of cardiovascular events among new users of different statins: a retrospective observational cohort study.
Heintjes EM; Penning-van Beest FJ; Johansson S; Stalenhoef AF; Herings RM
Curr Med Res Opin; 2009 Nov; 25(11):2621-9. PubMed ID: 19743959
[TBL] [Abstract][Full Text] [Related]
28. Altering the pathophysiology of atherosclerosis: the multidimensional role of statins.
Clearfield MB
J Am Osteopath Assoc; 2010 Apr; 110(4 Suppl 4):S2-6. PubMed ID: 20453192
[TBL] [Abstract][Full Text] [Related]
29. [Does statin therapy reduce the risk of stroke? A meta-analysis].
Sirol M; Bouzamondo A; Sanchez P; Lechat P
Ann Med Interne (Paris); 2001 Apr; 152(3):188-93. PubMed ID: 11431579
[TBL] [Abstract][Full Text] [Related]
30. Primary prevention of vascular events in patients with high levels of C-reactive protein: the JUPITER study.
Fonseca FA; Izar MC
Expert Rev Cardiovasc Ther; 2009 Sep; 7(9):1041-56. PubMed ID: 19764857
[TBL] [Abstract][Full Text] [Related]
31. [Statins in stroke prevention].
Gedikli O; Baykan M
Anadolu Kardiyol Derg; 2008 Jun; 8(3):217-22. PubMed ID: 18524729
[TBL] [Abstract][Full Text] [Related]
32. The gravity of JUPITER (Justification for the Use of Statins in Primary Prevention: An Intervention Trial Evaluating Rosuvastatin).
O'Keefe JH; Carter MD; Lavie CJ; Bell DS
Postgrad Med; 2009 May; 121(3):113-8. PubMed ID: 19491548
[TBL] [Abstract][Full Text] [Related]
33. Rosuvastatin in the management of hyperlipidemia.
Cheng JW
Clin Ther; 2004 Sep; 26(9):1368-87. PubMed ID: 15531000
[TBL] [Abstract][Full Text] [Related]
34. Effects of switching statins on achievement of lipid goals: Measuring Effective Reductions in Cholesterol Using Rosuvastatin Therapy (MERCURY I) study.
Schuster H; Barter PJ; Stender S; Cheung RC; Bonnet J; Morrell JM; Watkins C; Kallend D; Raza A;
Am Heart J; 2004 Apr; 147(4):705-13. PubMed ID: 15077101
[TBL] [Abstract][Full Text] [Related]
35. Inflammation, C-reactive protein, and atherothrombosis.
Ridker PM; Silvertown JD
J Periodontol; 2008 Aug; 79(8 Suppl):1544-51. PubMed ID: 18673009
[TBL] [Abstract][Full Text] [Related]
36. Do statins reduce the incidence of stroke in familial hypercholesterolemia?
Vuorio AF; Kovanen PT
Expert Rev Cardiovasc Ther; 2011 Mar; 9(3):349-53. PubMed ID: 21438814
[TBL] [Abstract][Full Text] [Related]
37. Statins for calcific aortic valve stenosis: into oblivion after SALTIRE and SEAS? An extensive review from bench to bedside.
Hermans H; Herijgers P; Holvoet P; Verbeken E; Meuris B; Flameng W; Herregods MC
Curr Probl Cardiol; 2010 Jun; 35(6):284-306. PubMed ID: 20451759
[TBL] [Abstract][Full Text] [Related]
38. Non-lipid effects of statins: emerging new indications.
Yildirir A; Müderrisoglu H
Curr Vasc Pharmacol; 2004 Oct; 2(4):309-18. PubMed ID: 15320810
[TBL] [Abstract][Full Text] [Related]
39. The benefit of statins in non-cardiac vascular surgery patients.
Stalenhoef AF
J Vasc Surg; 2009 Jan; 49(1):260-5. PubMed ID: 19174265
[TBL] [Abstract][Full Text] [Related]
40. Anti-inflammatory effects of statins in patients with aortic stenosis.
Pate GE; Tahir MN; Murphy RT; Foley JB
J Cardiovasc Pharmacol Ther; 2003 Sep; 8(3):201-6. PubMed ID: 14506545
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
